Literature DB >> 23642361

Whole-genome analysis, stem cell research, and the future of biobanks.

Thane Kreiner1, Stefan Irion.   

Abstract

The convergence of the genomic revolution and biobanking with rapid progress in stem cell research holds vast potential for personalized medicine and novel therapies. In this Forum, we explore social and ethical considerations emerging from strategies to realize the promise of these remarkable technologies.
Copyright © 2013 Elsevier Inc. All rights reserved.

Mesh：

Year:  2013        PMID： 23642361     DOI： 10.1016/j.stem.2013.04.024

Source DB:  PubMed          Journal:  Cell Stem Cell        ISSN： 1875-9777            Impact factor:   24.633


  5 in total

1.  Tracking and Predicting Human Somatic Cell Reprogramming Using Nuclear Characteristics.

Authors:  Kaivalya Molugu; Ty Harkness; Jared Carlson-Stevermer; Ryan Prestil; Nicole J Piscopo; Stephanie K Seymour; Gavin T Knight; Randolph S Ashton; Krishanu Saha
Journal:  Biophys J       Date:  2019-10-22       Impact factor: 4.033

Review 2.  Great expectations: autism spectrum disorder and induced pluripotent stem cell technologies.

Authors:  Emily Yang Liu; Christopher Thomas Scott
Journal:  Stem Cell Rev Rep       Date:  2014-04       Impact factor: 5.739

3.  Identifiability and privacy in pluripotent stem cell research.

Authors:  Rosario Isasi; Peter W Andrews; Jay M Baltz; Annelien L Bredenoord; Paul Burton; Ing-Ming Chiu; Sara Chandros Hull; Ji-Won Jung; Andreas Kurtz; Geoffrey Lomax; Tenneille Ludwig; Michael McDonald; Clive Morris; Huck Hui Ng; Heather Rooke; Alka Sharma; Glyn N Stacey; Clare Williams; Fanyi Zeng; Bartha Maria Knoppers
Journal:  Cell Stem Cell       Date:  2014-04-03       Impact factor: 24.633

4.  Newspaper coverage of biobanks.

Authors:  Ubaka Ogbogu; Maeghan Toews; Adam Ollenberger; Pascal Borry; Helene Nobile; Manuela Bergmann; Timothy Caulfield
Journal:  PeerJ       Date:  2014-07-31       Impact factor: 2.984

Review 5.  Aspects of Modern Biobank Activity - Comprehensive Review.

Authors:  Wiktor Paskal; Adriana M Paskal; Tomasz Dębski; Maciej Gryziak; Janusz Jaworowski
Journal:  Pathol Oncol Res       Date:  2018-05-05       Impact factor: 3.201
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.